United States · FDA National Drug Code directory
Senna S
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10135-669_441ef4c5-4902-159d-e063-6394a90aebd0
- Product NDC
- 10135-669
- Form
- TABLET
- Composition / generic term
- Docusate Sodium and Sennosides
- Labeler
- Marlex Pharmaceuticals Inc
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20181001
- Source listing expiry
- 20261231
Source-listed ingredients
- SENNOSIDES — 8.6 mg/1
- DOCUSATE SODIUM — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (10135-669-01) / 100 TABLET in 1 BOTTLE · 10135-669-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →